| |
|
|
|
Plus Therapeutics Inc  
|
|
3.09 0.66 (0.27%) |
01-25 16:00 |
|
Open: |
2.6 |
Pre close: |
2.43 |
Target:
|
3.89 
|
|
High: |
3.33 |
Low: |
2.58 |
Resistance:
|
3.33
3.89
|
|
Volume: |
4,310,638 |
Market Cap: |
15M |
Support:
|
2.50
1.98
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.50
|
MACD |
MACD(12,26):
|
0.12 |
|
MA(20): |
2.27 |
Signal(12,26,9): |
0.05 |
|
MA(100): |
2.37 |
Stochastic Oscillator |
%K(14,3):
|
77.37  |
|
MA(250): |
2.15 |
%D(3): |
77.23 |
|
Average Volume(K) |
3-Month: |
34471
|
52-Week |
High:
|
3.56 |
|
10-Days: |
63111 |
Low: |
0.93 |
|
RSI |
RSI(14):
|
80.67 |
Change(%): |
33.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-30.616 |
Return on Equity (ttm) |
-268.5 |
Shares Out. (M) |
4.78 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-25.5 |
Shares Float (M) |
4.63 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
6.20 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
11.04 |
|
Forward EPS |
-8.270 |
Gross Profit (p.s.) |
0.341 |
Shares Short (K) |
79 |
|
Book Value (p.s.) |
0.060 |
EBITDA (p.s.) |
-1.513 |
P/E |
-0.10 |
|
Sales Per Share |
0.312 |
Qtrly Earnings Growth |
0.00 |
P/BV |
51.50 |
|
Profit Margin |
-252.85 |
Operating Cash Flow
(M) |
-4.17 |
P/S |
9.91 |
|
Operating Margin |
-511.13 |
Levered Free Cash Flow
(M) |
-1.58 |
P/CF |
-3.54 |
|
|
|
|
|
|
